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OBJECTIVE — To perform comparative analyses of obstetric and perinatal outcomes be-
tweentype1diabeticpregnanciesandthegeneralobstetricpopulationinSwedenbetween1991
and 2003.
RESEARCH DESIGN AND METHODS — This was a population-based study. Data
were obtained from the Medical Birth Registry, covering 98% of all pregnancies in Sweden. A
total of 5,089 type 1 diabetic pregnancies and 1,260,207 control pregnancies were included.
Odds ratios (ORs) were adjusted for group differences in maternal age, parity, BMI, chronic
hypertensive disease, smoking habits, and ethnicity.
RESULTS — In type 1 diabetes, preeclampsia was signiﬁcantly more frequent (OR 4.47
[3.77–5.31]) as was delivery by cesarean section (5.31 [4.97–5.69]) compared with results for
the general population. Stillbirth (3.34 [2.46–4.55]), perinatal mortality (3.29 [2.50–4.33]),
and major malformations (2.50 [2.13–2.94]) were more common in type 1 diabetic than in
control pregnancies. The risk of very preterm birth (32 gestational weeks) was also higher
among type 1 diabetic women (3.08 [2.45–3.87]). The incidence of fetal macrosomia (birth
weight 2 SD above the mean) was increased in the diabetic group (11.45 [10.61–12.36]).
CONCLUSIONS — Type 1 diabetes in pregnancy is still associated with considerably in-
creased rates of adverse obstetric and perinatal outcomes. The eightfold increased risk for fetal
macrosomia in type 1 diabetic pregnancies is unexpected and warrants further investigation.
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T
ype 1 diabetes in pregnancy is asso-
ciated with increased risks of mater-
nal and fetal complications. In a
Swedish study from 1982 to 1985, the
perinatal mortality (3.1%) and stillbirth
rates (2.1%) were 4–5 times those of the
general population (1). Since then and af-
ter the introduction of tight glycemic
control,outcomesoftype1diabeticpreg-
nancies are considered to have improved
signiﬁcantly. However, objective and
unanimous estimates of improvement in
carearedifﬁculttoﬁnd.Morerecentstud-
ies on type 1 diabetic pregnancies have
reported various results: stillbirth and
perinatal mortality were still signiﬁcantly
increased in some studies (2–6), the risk
for major malformations varied from 2 to
10 times normal (2,4,6), and the inci-
dence of fetal macrosomia remained
markedly increased, despite apparently
good metabolic control with A1C levels
close to the normal range (7,8). Accord-
ingly, the aim of the St. Vincent Declara-
tion from 1989 (9), i.e., to abolish the
overt risks associated with pregnancy in
women with type 1 diabetes by the end of
the last century, has not been achieved.
There is no clear explanation for the wide
variation in perinatal outcomes for dia-
betic pregnancies. Differences in organi-
zation of health care, socioeconomic
factors, maternal characteristics, and pa-
tient compliance could account for some
of the observed differences. More favor-
able results reported from centers of ex-
cellence may reﬂect some selection bias.
Given the relatively low incidence of con-
genital malformations and perinatal mor-
tality, large studies are required for
accurate risk estimates, and variations in
outcomes for type 1 diabetic pregnancies
may be associated not only with diabetes
but also with other risk factor variations
in the general obstetric population.
The primary aim of this study was to
provide solid evidence for obstetric and
perinatal outcomes in type 1 diabetic
pregnancies. We compared outcomes in
5,000 type 1 diabetic pregnancies with
those in the general obstetric population
in Sweden over a period of 13 years
(1991–2003). The large numbers in-
cludedinthestudyofferedapossibilityto
obtain objective and precise estimates of
complications in diabetic pregnancies
and to adjust for potential confounders.
To facilitate interpretation of our results
in relation to organization of care and
change over time, we compared hospitals
in relation to the number of type 1 dia-
betic pregnancies managed per year and
subgrouped outcomes in relation to cal-
endar period of birth.
RESEARCH DESIGN AND
METHODS— This prospective study
wasbasedoninformationfromtheSwed-
ishMedicalBirthRegistry(MBR)between
1991 and 2003. The MBR is regularly
evaluated by the Swedish National Board
of Health, and in the latest evaluation, it
was found to capture 98% of all preg-
nanciesinSweden.Thequalityofdatahas
also been found to be reliable (10). This
study included all type 1 diabetic preg-
nancies, and pregnant women without a
diagnosisoftype1diabetesservedascon-
trol subjects. In both groups, only single-
ton births were included.
We used the ICD-9 and ICD-10.
Since 1991, pregestational diabetes can
be separated from gestational diabetes
mellitus (GDM) by ICD-9, and since
1997, type 1 diabetes, type 2 diabetes,
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personal communication). Therefore, the
overall contribution from any type 2 dia-
betic woman included in the diabetic
population during the ﬁrst 6 years of the
study period was considered small and
insigniﬁcant.
In Sweden, pregnancy care is stan-
dardized and free of charge. Virtually all
pregnant women comply with seven to
nine antenatal visits (one to two to a phy-
sicianandtheremaindertoamidwife).In
diabetic pregnancies, the number of ante-
natal visits is increased. Of all pregnant
women, 97% have an ultrasound exami-
nation at 17–18 postmenstrual weeks to
determine gestational age.
At the ﬁrst antenatal visit, the woman
was interviewed about her medical his-
tory, previous births, and complications
during the previous pregnancy, delivery,
and neonatal period. Anthropometric
data and smoking habits were recorded.
Pregnancy and delivery data were pro-
spectively entered into the MBR, which
also included neonatal anthropometry
and diagnoses. For this purpose, standard-
ized individual obstetric and pediatric
forms were used. Maternal characteristics
were age, parity, prepregnancy weight,
height, smoking habits, and place of birth
(i.e., whether the mother was born in the
Nordic countries [Sweden, Finland, Den-
mark, Norway, or Iceland] or elsewhere).
These variables, except ethnicity, were all
collected from the MBR. Country of birth
was established by linking the MBR to the
Civil Registration. Maternal prepreg-
nancy BMI was calculated (weight in ki-
logramsdividedbythesquareofheightin
meters). We deﬁned smoking categories
as no smoking, smoking 10 cigarettes
per day, or smoking 10 cigarettes per
day.Maternalcomplicationsduringpreg-
nancy and delivery and fetal and neonatal
complications were classiﬁed according
to ICD-9 and -10. All diagnoses were
made by a physician at the time of hospi-
tal discharge, and copies of obstetric and
pediatric records were forwarded to the
MBR. Chronic hypertensive disease
(ICD-9 code 401 or 642 A; ICD-10 code
I10 or O10.0) was deﬁned as blood pres-
sure 140/90 mmHg diagnosed before
pregnancy or before 20 weeks of gesta-
tion. Pregnancy-induced hypertension
(PIH) was deﬁned as resting blood pres-
sure 140/90 mmHg in the second half
of pregnancy (ICD-9 code 642 D3;
ICD-10 code O13). Preeclampsia was de-
ﬁned as PIH and proteinuria of 0.3
g/day or 1 on a urine dipstick (ICD-9
code642Eor642F;ICD-10codeO14.0,
O14.1, or O15). Mild preeclampsia was
deﬁned as diastolic blood pressure from
90to109mmHgcombinedwithprotein-
uria of 5 g/day or 1–2 on a urine dip-
stick (ICD-9 code 642E; ICD 10 code
O14.0). Severe preeclampsia was deﬁned
as preeclampsia with either a diastolic
blood pressure 110 mmHg or protein-
uria5g/dayorboth(ICD-9code642F;
ICD-10 code O14.1 or O15). Preterm
birth was deﬁned as delivery before 37
gestational weeks and very preterm birth
as delivery before 32 weeks. During the
study period, stillbirth was deﬁned in
Sweden as intrauterine death occurring
after 28 weeks of gestation.
Perinatal death was deﬁned as the
combined rate of stillbirth and mortality
within the ﬁrst week of life. Neonatal
mortality was deﬁned as death within the
ﬁrst 7 days of life (early neonatal death)
and within the ﬁrst 28 days of life. Fetal
distress was present whenever vacuum
extraction or cesarean section was per-
formed as a result of suspected or man-
ifest fetal hypoxia. Large for gestational
age (LGA) and small for gestational age
(SGA) were deﬁned as birth weights 2
SD above or below the mean for normal
fetal growth according to Swedish refer-
ence data, respectively (11). The corre-
sponding percentile limits for LGA and
SGA are 97.5 and 2.5 percentiles, re-
spectively. Apgar scores between 0 and 3
at5minofpostnatalagewererecordedas
well as brachial plexus injury in vaginally
delivered infants. Neonatal respiratory
disorders were classiﬁed according to
Hjalmarson (12). Transient tachypnea,
respiratory distress, and other diagnoses
of respiratory disturbances (ICD-9 codes
769 and 770G; ICD-10 all codes starting
with P 22, P 24, P 25, and P 26) were
included in the analysis. A malformation
was classiﬁed by the MBR as major if it
was fatal or potentially life-threatening or
if it was likely to lead to serious handicap
or major cosmetic defect if not surgically
corrected. We compared the outcomes
between hospitals managing 10 (total
number of patients 2,190), 10–19 (n 
1,910), and 19 (n  989) type 1 dia-
betic pregnancies per year. We also cate-
gorized the study period into the ﬁrst 7
years (1991–1997) and the next 6 years
(1998–2003).
Statistical methods
Means  SDs were calculated. Student t
test and the 
2 test were used for compar-
isonofgroupmeansandproportions.Lo-
gistic regression was used to evaluate any
association between maternal type 1 dia-
betes and outcomes. In multivariate anal-
yses, the point estimates for outcomes
were adjusted for maternal age, BMI, par-
ity, chronic hypertensive disorder, smok-
ing habits, and ethnicity. Because of
missing data on prepregnancy BMI, mul-
tivariate analyses were limited to 954,292
mothers. All statistical analyses were per-
formed using SPSS (version 15.0).
RESULTS— In total, 5,089 pregnant
women with and 1,260,207 pregnant
women without type 1 diabetes were
included.
Maternal characteristics
Women with type 1 diabetes more often
had prepregnancy hypertension, were of
Nordic origin, and had higher BMI than
the general obstetric population. Mater-
nal age, parity, and smoking habits
showed minor but statistically signiﬁcant
differencesbetweenwomenwithdiabetes
and control subjects (Table 1).
Pregnancy complications
The risks for PIH and preeclampsia, fetal
distress and fetal loss, and instrumental
delivery and cesarean section were all in-
creased in the diabetic cohort, also after
adjustment for potential confounders
(Tables 2 and 3). In the diabetic cohort,
the majority of stillbirths (58 of 69) oc-
curred between 34 and 40 gestational
weeks. In vaginal deliveries, shoulder
dystocia occurred in 13.7% of infants de-
livered by diabetic mothers compared
with 0.2% of control infants (P  0.001),
which corresponds to an adjusted odds
ratio(OR)of11.08(95%CI8.22–14.93).
Fetal growth
Infants of diabetic mothers were born at a
lower gestational age (mean 267 vs. 278
days,P0.001)thancontrolinfants.De-
spitethis,birthweights(3,684gvs.3,551
g, P  0.001) were higher in infants of
diabetic mothers. Birth weights were
close to normally distributed in the dia-
betic cohort with only a minor difference
between the mean and median birth
weight. After correction for gestational
age and sex, birth weights were increased
in the diabetic group: 31% of the infants
borntotype1diabeticmotherswereLGA
compared with 3.6% of infants born to
mothers in the general population. Birth
weights4.5and5kg,respectively,were
signiﬁcantly more common in the dia-
betic group (12.6 and 2.7%) than among
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0.0001). The adjusted OR for SGA was
signiﬁcantly lower in the type 1 diabetic
groupthaninthecontrolgroup(Table3).
Malformations
In the diabetic group, there was a twofold
increase in the incidence of major malfor-
mations (Table 3). Major malformations
were the leading cause of neonatal death
(10 of 36) in the diabetic cohort.
Neonatal mortality and morbidity
Perinatal and neonatal mortalities were
signiﬁcantly increased in diabetic preg-
nancies. Low Apgar scores (0–3) at 5 min
of postnatal age, Erb palsy, and respira-
tory distress were all signiﬁcantly and
muchmorecommonininfantsofdiabetic
mothers (Table 3).
Outcomes in relation to hospital size
Fetal distress and transient tachypnea
were more common in larger hospitals
caring for 19 type 1 diabetic pregnant
women per year. Except from these two
outcomes, there were no signiﬁcant dif-
ferences in obstetric and perinatal out-
come among hospitals of different size.
Outcomes in relation to calendar
period of birth
The incidence of LGA increased in the di-
abetic group from 27.6% in the ﬁrst to
35.0% in the second period of the study
(P  0.001). The proportion of LGA in-
fantsincreasedsigniﬁcantlyinthegeneral
obstetric population also, from 3.38% in
the ﬁrst to 3.77% in the last study period
(P  0.001).
Over time, the proportion of women
with BMI 30 kg/m
2 increased in both
groups.Intheﬁrststudyperiod,13.2%of
type 1 diabetic women were obese com-
pared with 18.4% during the second pe-
riod (P  0.001). The corresponding
ﬁguresforcontrolwomenwere7.3%(pe-
riod 1) and 11.3% (period 2).
CONCLUSIONS — This study showed
that pregnant type 1 diabetic women still
have markedly elevated incidences of ob-
stetric and fetal complications such as
preeclampsia, prematurity, malforma-
tions, perinatal mortality, and neonatal
morbidity. The risk for a LGA infant was
particularly increased among women
with diabetes.
The strength of the present study is
the population-based cohort, including
both stillborn and live-born infants. Pop-
ulation-baseddataareessentialforassess-
ing solid estimates of complication rates,
for planning of health care, for patient
counseling,andforcomparisonsbetween
countries and populations. The large
numbers of patients allowed for detailed
riskassessments,alsoincludingrarecom-
plications such as perinatal mortality and
malformations. Potential confounding by
other risk factors, such as age, parity,
BMI, and chronic hypertensive disease,
could be controlled for.
We cannot exclude the possibility
that during the ﬁrst study period some
type 2 diabetic patients could have been
included in the study population because
the ICD-9 codes just differ between pre-
gestational diabetes and GDM. However
the rate of type 2 diabetes in pregnancy is
lowinSweden.Ifanything,thesmallfrac-
tion of type 2 diabetic women that may
have been included most likely contrib-
uted to a dilution of the complication
rates observed in type 1 diabetic women.
Accordingly, this potential misclassiﬁca-
tion bias does not invalidate our ﬁndings.
One limitation is that the MBR does
not contain data on duration of diabetes,
prevalence of preexisting microangiopa-
thy, or glycemic control during preg-
nancy. Another limitation is the lack of
data regarding the number of induced
abortions due to malformations. The
present analysis conﬁrms the elevated
risks for preeclampsia and PIH in women
withtype1diabetes.Thisisinaccordance
withﬁndingsinothercomparablestudies
(4,13). The precise explanation for this
ﬁnding is not known. However, chronic
hypertensive disease, nephropathy, and
poor glycemic control are probably con-
tributing factors (14–16).
Stillbirths in diabetic pregnancies
(1.5%) were 5 times those in the back-
ground population. Although markedly
reduced compared with data from 40
years ago (17), excess risk for stillbirth is
still seen in diabetic pregnancies in
agreement with contemporary studies
(4,13,18). The underlying mechanisms
Table 1—Maternal characteristics in type 1 diabetes and the general obstetric population in
Sweden 1991–2003
Type 1 diabetes Control
n 5,089 1,260,207
Nordic origin (%) 92.6 86.8
Maternal age (years) 29.6  5.1 29.0  5.1
Primapara (%) 44.5 42.4
Height (cm) 166  6.3 166  6.2
Prepregnancy weight (kg) 71.4  13.4 66.5  12.1
Prepregnancy BMI (kg/m
2) 25.9  4.6 24.0  4.1
Chronic hypertensive disease (%) 2.1 0.24
No smoking in pregnancy (%) 82.0 83.8
Smoking
10 cigarettes /day (%) 10.9 10.6
10 cigarettes/day (%) 7.1 5.6
Data are means  SD or proportions in %. With the exception of maternal height, all differences between
type 1 diabetic and control women are statistically signiﬁcant with P  0.001 (Student t test or 
2 test).
Table 2—Pregnancy complications and mode of delivery in type 1 diabetic and control
pregnancies
Outcome variable
Proportions (% ) OR (95% CI) for group differences
Type 1
diabetes Nondiabetes Crude Adjusted
PIH 1.6 0.87 1.93 (1.50–2.49) 1.53 (1.18–1.99)
Preeclampsia, mild 9.7 2.0 5.37 (4.81–6.00) 4.30 (3.83–4.83)
Preeclampsia, severe 4.3 0.8 5.58 (4.75–6.57) 4.47 (3.77–5.31)
Cesarean section 46 12 5.85 (5.49–6.25) 5.31 (4.97–5.69)
Vacuum extraction/forceps 9.6 6.6 1.48 (1.33–1.66) 1.41 (1.25–1.58)
Data are proportions or OR (95% CI). n  5,089 for diabetic pregnancies; n  1,260,207 for control
pregnancies. Adjusted OR, OR adjusted for group differences in maternal age, BMI, parity, chronic hyper-
tensive disorder, smoking habits, and ethnicity.
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not fully understood. Maternal and fetal
hyperglycemia are associated with
chronic fetal hypoxia, as indicated by a
correlation between the concentration of
erythropoietininamnioticﬂuidandante-
natal glycemic control (19). Lauenborg et
al. (20) reported 25 cases of stillbirth in
type 1 diabetic pregnancies and found no
cause of death other than poor maternal
glycemic control in 9 cases. Similarly,
Hanson and Persson (1) recorded signiﬁ-
cantlyhigherA1Clevelsinthelasttrimes-
ter in 5 of 10 stillbirths in diabetic
mothers. Fetal hypoxia may also explain
why fetal distress as an indication for in-
strumental delivery or cesarean section
was nearly 3 times more common in dia-
betic pregnancies compared with control
pregnancies.
Major malformations occurred 2–3
times more often in the diabetic group.
This occurrence is comparable to some
(4,6)butnotallreports.Evenhigherrates
of major malformations compared with
those in the control group have been re-
ported from the U.K. (2). Differences in
metabolic control (21), in deﬁnitions of
major malformation, in the number of
early induced abortions, and in intrapar-
tum deaths may contribute to this dis-
crepancy. The malformation rate should
also be interpreted in view of the fact that
inSweden,thereisnofortiﬁcationoffood
with folic acid. Prepregnancy counseling
to women with type 1 diabetes includes
therecommendationforfolicacidsupple-
mentation, but we have no data regarding
compliance with this recommendation or
folic acid intake before conception.
Rates of instrumental delivery (9.6%)
and cesarean section (46%) were much
higher in the diabetic group. This ﬁnding
is in agreement with other reports (4).
Studies on type 1 diabetic pregnancies
fromFinlandandDenmarkreportedeven
higher rates of cesarean sections (63.5
and 55.9%, respectively) (5,13). The
lower cesarean section rate in Sweden
could be explained partly by a more ex-
pectative policy, where spontaneous ini-
tiation of delivery is encouraged. This
suggestion is supported by higher num-
bers of preterm deliveries reported from
Finland and Denmark: 30 and 42%, re-
spectively (5,13), vs. 22% in our study.
Many of the preterm deliveries in other
studies were performed before the start of
or after induction of labor (13). Perinatal
mortalityintype1diabeticpregnanciesin
Sweden has decreased from 3.1% in
1982–1985 (1) to 2.0% in the present
study, and it is in the lower range of pre-
viously recorded rates, varying from 1.3
to 6.6% (4–6,13,18,22). Nevertheless,
perinatal mortality in type 1 diabetic
womenexceedsthatincontrolwomenby
4 times, mainly because of the increased
risk for stillbirth. To a lesser extent, neo-
natal mortality rates were also increased
in infants of diabetic women, most likely
because of their higher incidence of mal-
formations, preterm delivery, and birth
asphyxia.Anunexpectedobservationwas
the markedly increased incidence of fetal
macrosomia in diabetic pregnancies. The
incidence of LGA (31%) was 8 times
that of the control group. In comparison
with Swedish data from 1982–1985, the
incidence of LGA has increased 11% in
absolute values and 50% relatively (1).
The risk for LGA increased signiﬁcantly
over time in the present study. High rates
of macrosomia have also been reported
from Holland (28.4%) and Finland
(34.7%) (4,5). It is unlikely that the in-
creased LGA incidence is a consequence
of deterioration in metabolic control, as
both the stillbirth and major malforma-
tion rates have declined. One could spec-
ulate that a contributing factor to the
increasing incidence of LGA is a decreas-
ing rate of microangiopathy (23). Interac-
tions with other determinants of birth
weight, such as prepregnancy BMI, may
also contribute to this ﬁnding. However,
theexcessriskforanLGAinfantremained
high (OR 11, 45) even after adjustment
for maternal BMI.
Very preterm delivery was 3 times
thatofthecontroldeliveries,contributing
to the higher incidence of neonatal mor-
bidity such as respiratory distress syn-
drome in the offspring of diabetic
mothers.Wealsofoundan8timeshigher
incidence of Erb palsy in the offspring of
diabetic mothers than in the offspring of
normal mothers. It is well recognized that
infants of mothers with diabetes have a
smaller head-to-shoulder ratio. The
disproportionate body constitution in-
creases the propensity of shoulder dystocia
and Erb palsy, and the risk of these com-
plicationsalsoincreaseswithlargersizeof
thebaby.Thereisnoclearexplanationfor
the variation in obstetric and perinatal
outcomes of type 1 diabetic pregnancies
among different countries. The discrep-
ancy in reported rates of complications
could result in part from differences in
organization of health care, socioeco-
nomic factors, and patient compliance. In
Sweden, antenatal care of pregnant
women with diabetes is usually pre-
formed in hospitals. The population is
scattered over a large geographical area,
which precludes centralization of care to
regional centers. Almost half of the preg-
nantwomenwithdiabetesattendedsmall
clinics caring for 10 pregnant type 1 di-





otherwise) OR (95% CI) for group differences
Type 1
diabetes Control Crude Adjusted
Stillbirth 1.5 0.3 4.04 (3.02–5.40) 3.34 (2.46–4.55)
Fetal distress 14 6.2 2.45 (2.24–2.69) 2.34 (2.12–2.58)
Perinatal mortality (‰) 20 4.8 4.02 (3.11–5.20) 3.29 (2.50–4.33)
Neonatal mortality, 0–7 days (‰) 5.1 1.8 2.91 (1.97–4.28) 3.05 (1.68–5.55)
Neonatal mortality, 0–28 days (‰) 7.0 2.2 3.08 (2.02–4.70) 2.67 (1.72–4.16)
Birth 37 weeks gestational age 21 5.1 5.27 (4.88–5.71) 4.86 (4.47–5.28)
Birth 32 weeks gestational age 2.3 0.7 3.58 (2.89–4.44) 3.08 (2.45–3.87)
LGA 31 3.6 12.2 (11.4–13.1) 11.4 (10.6–12.4)
SGA 2.3 2.5 0.80 (0.63–1.02) 0.71 (0.55–0.91)
Major malformations 4.7 1.8 2.70 (2.37–3.08) 2.50 (2.13–2.94)
Apgar score 7 at 5 min 3.1 1.1 2.98 (2.54–3.50) 2.60 (2.14–3.17)
Apgar score 4 at 5 min 0.80 0.30 2.60 (1.79–3.78) 2.39 (1.64–3.51)
Erb palsy* 2.1 0.25 7.91 (5.77–10.8) 6.69 (4.81–9.31)
Respiratory distress syndrome 1.0 0.20 4.88 (3.51–6.81) 4.65 (2.20–9.84)
Respiratory disorders 9.5 2.6 4.02 (3.67–4.42) 3.42 (3.04–3.85)
DataareproportionsorOR(95%CI).AdjustedOR,ORadjustedforgroupdifferencesinmaternalage,BMI,
parity, chronic hypertensive disorder, smoking habits, and ethnicity. *Vaginal deliveries only.
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ally provided by multidisciplinary teams
with a special interest in diabetes. All pa-
tientsaregiveninsulinandequipmentfor
insulin administration, as well as equip-
ment for home monitoring of blood glu-
cose. The importance of prepregnancy
planning is emphasized, starting initially
at the pediatric clinic. National recom-
mendations concerning standardization
of care are available. Before and during
the study period, diabetologists provided
health care personnel with information
and guidelines for medical management
of pregnant diabetic women. This work
seems to have been successful as major
outcomes did not vary in relation to
hospital size. Similar experience has
been reported from Finland where de-
centralization of care for diabetic pa-
tients did not signiﬁcantly increase the
number of adverse pregnancy outcomes
(5).However,wecannotexcludethepos-
sibility that the higher incidence of fetal
distressandtransienttachypneaobserved
in larger hospitals caring for 19 preg-
nant type 1 diabetic women per year re-
ﬂectedaselectionwithwomenhavingthe
most complicated pregnancies being
transferred to the larger hospitals. Given
suchselection,smallerhospitalswouldbe
expected to have better results. The num-
ber of preterm births and cases of severe
preeclampsia did not differ between large
and smaller clinics, but without a more
detailed analysis of the case mix of dia-
betic women in different hospitals, the
issue of whether centralization occurred
has to be left open.
In summary, the present study dem-
onstrates that incidence of obstetric and
perinatal complications is still high in the
diabetic pregnancy. An intriguing ﬁnding
is the high incidence of fetal macrosomia
and the fact that the incidence is increas-
ing over time. The etiology behind the in-
creased risk of fetal death and fetal
macrosomia in the type 1 diabetic preg-
nancy is not fully understood and war-
rants further investigation.
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